PAHC
Phibro Animal Health Corporation
NASDAQ: PAHC · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$52.50
-3.30% today
Updated 2026-04-29
Market cap
$2.13B
P/E ratio
23.23
P/S ratio
1.45x
EPS (TTM)
$2.26
Dividend yield
0.88%
52W range
$18 – $60
Volume
0.3M
Phibro Animal Health Corporation (PAHC) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $248.30M | $271.90M | $325.07M | $361.63M | — | — | $440.91M | $474.14M | $472.32M | $493.32M | $610.37M | $623.40M | $671.68M | $726.67M | $784.10M | $841.33M | $931.70M | $971.40M | $982.18M | $1.36B |
| Cash & equivalents | $8.70M | $12.00M | $6.99M | $13.52M | — | — | $53.90M | $27.37M | $11.82M | $29.22M | $33.60M | $56.08M | $29.17M | $57.57M | $36.34M | $50.21M | $74.25M | $41.28M | $70.61M | $68.04M |
| Current assets | $176.60M | $191.50M | — | — | — | — | $301.89M | $296.39M | $299.29M | $313.73M | $342.83M | $363.67M | $415.46M | $466.16M | $451.84M | $498.91M | $566.23M | $585.72M | $601.00M | $810.61M |
| Total liabilities | $332.00M | $359.90M | $363.47M | $415.50M | — | — | $529.14M | $543.08M | $457.17M | $463.69M | $519.89M | $472.24M | $486.73M | $510.66M | $595.90M | $602.80M | $669.26M | $688.89M | $725.54M | $1.08B |
| Current liabilities | $101.00M | $97.80M | $95.01M | $96.61M | — | — | $125.86M | $115.40M | $112.44M | $111.33M | $108.78M | $115.80M | $143.22M | $154.23M | $157.24M | $164.12M | $190.83M | $176.00M | $204.15M | $293.47M |
| Long-term debt | — | $248.56M | $247.27M | $289.13M | — | — | $344.77M | $365.54M | $286.42M | $3.00M | $69.00M | $65.00M | $70.00M | $96.00M | $368.26M | $382.71M | $417.93M | $452.54M | $458.29M | $702.43M |
| Shareholder equity | $-83.80M | $-88.00M | — | — | — | — | $-88.23M | $-68.94M | $15.15M | $29.63M | $90.48M | $151.16M | $184.95M | $216.01M | $188.20M | $238.53M | $262.44M | $282.51M | $256.64M | $285.68M |
| Retained earnings | $-89.90M | $-96.60M | — | — | — | — | $-116.01M | $-94.12M | $-97.25M | $-36.97M | $33.96M | $82.75M | $131.56M | $168.93M | $183.06M | $218.01M | $247.75M | $260.91M | $243.89M | $272.70M |
| Accounts receivable | $59.00M | $76.10M | — | — | — | — | $99.14M | $99.14M | $113.86M | $111.10M | $123.79M | $125.85M | $135.74M | $159.02M | $126.52M | $146.85M | $166.54M | $163.48M | $169.45M | $227.98M |
| Inventory | $96.80M | $89.40M | $110.44M | $106.65M | — | — | $120.12M | $140.03M | $143.18M | $149.79M | $167.69M | $161.23M | $178.17M | $198.32M | $196.66M | $216.31M | $259.16M | $277.57M | $265.91M | $444.43M |
| Goodwill | — | — | — | $1.72M | — | — | $1.72M | $12.61M | $12.61M | $12.61M | $21.12M | $23.98M | $27.35M | $27.35M | $52.68M | $52.68M | $53.23M | $53.27M | $54.56M | $59.65M |